PALBOCICLIB vs RUXOLITINIB: Which Drug Is Safer?
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
PALBOCICLIB vs RUXOLITINIB: Safety Overview
| Metric | PALBOCICLIB | RUXOLITINIB |
|---|---|---|
| Total FAERS Reports | 91,024 | 68,133 |
| Deaths Reported | 11,066 | 10,908 |
| Death Rate | 12.2% | 16.0% |
| Hospitalizations | 13,442 | 14,461 |
| Average Patient Age | 66.0 yrs | 59.7 yrs |
| % Female Patients | 97.7% | 48.8% |
| FDA Approval Date | Feb 3, 2015 | Nov 16, 2011 |
| Manufacturer | Pfizer Laboratories Div Pfizer Inc | Incyte Corporation |
| Route | ORAL | TOPICAL |
| Marketing Status | Prescription | Prescription |